Literature DB >> 2777409

Generation of a recombinant mouse-human chimaeric monoclonal antibody directed against human carcinoembryonic antigen.

N Hardman1, L L Gill, R F De Winter, K Wagner, M Hollis, F Businger, D Ammaturo, F Buchegger, J P Mach, C Heusser.   

Abstract

A procedure was devised for the identification and specific cloning of functionally rearranged variable region immunoglobulin (Ig) gene segments from genomic DNA of a murine hybridoma cell line which produces a high-affinity monoclonal antibody (MAb) directed against human carcinoembryonic antigen (CEA). The cloned, functionally-rearranged murine Ig H-chain and L-chain variable region gene segments were incorporated into plasmid vectors capable of directing the expression of a chimaeric mouse-human antibody molecule with human (gamma 4, kappa) constant region sequences. Expression plasmids were transfected into a mouse myeloma cell line by electroporation and transfectomas secreting functional chimaeric antibody selected. Chimaeric antibody generated by transfectomas was analysed and shown to compete effectively with its murine counterpart for binding to the CEA epitope, and to have an equivalent antigen-binding affinity. This anti-CEA recombinant antibody should find application in in vivo diagnosis by immunoscintigraphy of human colonic carcinoma, and possibly also in therapy of the disease, overcoming some of the difficulties associated with the repeated use of non-human immunoglobulins in human patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777409     DOI: 10.1002/ijc.2910440308

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Secretion of a single-gene-encoded immunoglobulin from myeloma cells.

Authors:  L Shu; C F Qi; J Schlom; S V Kashmiri
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

2.  Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen.

Authors:  S Folli; G Wagnières; A Pèlegrin; J M Calmes; D Braichotte; F Buchegger; Y Chalandon; N Hardman; C Heusser; J C Givel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

3.  Differences in biodistribution of the anti-(carcinoembryonic antigen) murine monoclonal antibody CE-25, its F(ab')2 fragment and its intact mainly human chimeric form CE 4-8-13. Dependence on tumour size and amount of antibody injected.

Authors:  G Westera; T Rülicke; A Smith; S Duewell
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

4.  Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model.

Authors:  A Leconte; V Garambois; M Ychou; B Robert; D Pourquier; A Terskikh; J P Mach; A Pèlegrin
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

5.  CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.

Authors:  Stéphanie Corgnac; Rachel Perret; Laurent Derré; Lianjun Zhang; Kathrin Stirnemann; Maurice Zauderer; Daniel E Speiser; Jean-Pierre Mach; Pedro Romero; Alena Donda
Journal:  Cancer Immunol Immunother       Date:  2012-12-15       Impact factor: 6.968

6.  Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.

Authors:  C A Vogel; A Bischof-Delaloye; J P Mach; A Pèlegrin; N Hardman; B Delaloye; F Buchegger
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

7.  Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers.

Authors:  Véronique Garambois; Fabienne Glaussel; Elodie Foulquier; Marc Ychou; Martine Pugnière; Robin X Luo; Binyam Bezabeh; André Pèlegrin
Journal:  BMC Cancer       Date:  2004-10-15       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.